Insider · CIK 0001769740
Ariel Hurley
officer
Files at BPMC (Blueprint Medicines Corp). First filing Dec 16, 2024, latest May 7, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $1.1M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 7Weak | Blueprint Medicines Corp | $284k 2,752 shares | -14% | - | |
| 40Moderate | Blueprint Medicines Corp | $118k 1,326 shares | -7% | - | |
| 29Weak | Blueprint Medicines Corp | $297k 3,203 shares | -15% | - | |
| 12Weak | Blueprint Medicines Corp | $225k 2,250 shares | -13% | - | |
| 11Weak | Blueprint Medicines Corp | $170k 1,819 shares | -11% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 3, 2025 | BPMC BLUEPRINT MEDICINES CORP | 2,250 0.00% of outstanding | $217k | Mar 3, 2025 | $395k |
| Dec 12, 2024 | BPMC BLUEPRINT MEDICINES CORPORATION | 5,022 0.01% of outstanding | $474k | Dec 12, 2024 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | AGrant or award Common Stock | +2,460 | - | - | 19,524 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Common Stock | -16,146 | - | - | 3,378 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | UTender of shares Common Stock | -3,378 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,250 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,000 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -11,399 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,751 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -6,375 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,750 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -9,494 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -7,007 | - | - | 0 | Jul 21, 2025 |
| May 5, 2025 | BPMC Blueprint Medicines Corp | MOption exercise Common Stock10b5-1 | +2,752 | $54.13 | $149k | 19,696 | May 7, 2025 |
| May 5, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock10b5-1 | -1,252 | $102.51 | $128k | 18,444 | May 7, 2025 |
| May 5, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock10b5-1 | -1,400 | $103.57 | $145k | 17,044 | May 7, 2025 |
| May 5, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock10b5-1 | -100 | $104.78 | $10k | 16,944 | May 7, 2025 |
| May 5, 2025 | BPMC Blueprint Medicines Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,752 | $0.00 | $0 | 2,751 | May 7, 2025 |
| Mar 5, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock | -1,326 | $88.80 | $118k | 16,944 | Mar 7, 2025 |
| Mar 1, 2025 | BPMC Blueprint Medicines Corp | AGrant or award Common Stock10b5-1 | +6,506 | $0.00 | $0 | 21,473 | Mar 4, 2025 |
| Mar 3, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock10b5-1 | -775 | $89.63 | $69k | 20,698 | Mar 4, 2025 |
| Mar 3, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock10b5-1 | -238 | $90.92 | $22k | 20,460 | Mar 4, 2025 |
| Mar 3, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock10b5-1 | -631 | $92.00 | $58k | 19,829 | Mar 4, 2025 |
| Mar 3, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock10b5-1 | -484 | $93.42 | $45k | 19,345 | Mar 4, 2025 |
| Mar 3, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock10b5-1 | -1,075 | $95.16 | $102k | 18,270 | Mar 4, 2025 |
| Mar 1, 2025 | BPMC Blueprint Medicines Corp | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +7,007 | $95.67 | $670k | 7,007 | Mar 4, 2025 |
| Jan 13, 2025 | BPMC Blueprint Medicines Corp | MOption exercise Common Stock10b5-1 | +2,250 | $36.05 | $81k | 17,217 | Jan 15, 2025 |
| Jan 13, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock10b5-1 | -2,250 | $100.00 | $225k | 14,967 | Jan 15, 2025 |
| Jan 13, 2025 | BPMC Blueprint Medicines Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,250 | $0.00 | $0 | 2,250 | Jan 15, 2025 |
| Dec 12, 2024 | BPMC Blueprint Medicines Corp | MOption exercise Common Stock10b5-1 | +1,600 | $15.01 | $24k | 16,786 | Dec 16, 2024 |
| Dec 12, 2024 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock10b5-1 | -1,200 | $92.88 | $111k | 15,586 | Dec 16, 2024 |
| Dec 12, 2024 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock10b5-1 | -619 | $93.99 | $58k | 14,967 | Dec 16, 2024 |
| Dec 12, 2024 | BPMC Blueprint Medicines Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,600 | $15.01 | $24k | 0 | Dec 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.